GCGraziano Di Cianni

Graziano Di Cianni

*This is an algorithmically generated author record based on publicly available information.

Graziano Di Cianni has a total of 58 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Temporal Trends and Determinants of Gestational Diabetes Mellitus and Perinatal Outcomes in Tuscany, Italy (2010–2021)

    by Giuseppe Seghieri, Elisa Gualdani, Paolo Francesconi, Flavia Franconi, Graziano Di Cianni

    Background/Objectives: This population-based observational study with a repeated cross-sectional design included singleton live births occurring in Tuscany, Italy, between 2010 and 2021, identified through regional Delivery Assistance Certificates (CeDAP) and linked with administrative healthcare databases. The study aimed to assess temporal trends in the prevalence of gestational diabetes mellitus (GDM) and to evaluate the contribution of major risk factors—particularly pregestational obesity, maternal age, parity, and origin from high-pressure migration countries (HPMC)—to GDM and related maternal–neonatal outcomes. The rationale for the study derives from the increasing worldwide prevalence of GDM, driven by changes in diagnostic criteria as well as evolving maternal demographic and metabolic risk profiles. Methods: The study included 266,394 singleton live births. GDM was identified using a previously validated algorithm based on insulin prescriptions, diabetes specialist visits, attendance to education programs, and postpartum oral glucose tolerance testing. Temporal trends in GDM, pregestational obesity, HPMC origin, and maternal–neonatal outcomes were assessed. Multivariable Poisson regression models with robust variance estimation were used to estimate adjusted prevalence ratios (PRs) and 95% confidence intervals (CIs) for GDM and adverse outcomes, including preterm birth, macrosomia, neonatal distress, and cesarean delivery. Results: During the study period, the annual number of births declined, whereas the overall mean prevalence of GDM was 11.37% and increased steadily from 8.23% in 2010 to 14.43% in 2021, corresponding to a relative increase of approximately 75%. Pregestational obesity and pregnancies among women from HPMC also increased over time. Multivariable analysis showed that pregestational obesity, advanced maternal age, multiparity, and HPMC origin were major independent determinants of GDM. Pregestational obesity emerged as the most important variable associated with both GDM and maternal–neonatal complications, including macrosomia, cesarean delivery, and neonatal distress, often showing stronger associations than GDM itself. Macrosomia and cesarean delivery declined over time, whereas preterm birth increased among pregnancies complicated by GDM. An inverse association between GDM and fetal macrosomia was observed in adjusted models, possibly reflecting effective clinical management, earlier delivery strategies, or algorithm-related selection effects. Conclusions: GDM prevalence increased substantially in Tuscany between 2010 and 2021 despite declining birth rates. This increase appears to be mainly associated with rising pregestational obesity, older maternal age, multiparity, and changes in population composition related to migration from HPMC. Adverse maternal–neonatal outcomes were more strongly associated with pregestational obesity and maternal age than with GDM itself, suggesting that preventive strategies targeting metabolic health before pregnancy may be crucial for reducing both GDM and related complications. Monitoring temporal trends in GDM and its risk factors may also serve as an indirect indicator of the effectiveness of regional healthcare policies.

  • Open Access

    Temporal Trends and Determinants of Gestational Diabetes Mellitus and Perinatal Outcomes in Tuscany, Italy (2010–2021)

    by Giuseppe Seghieri, Elisa Gualdani, Paolo Francesconi, Flavia Franconi, Graziano Di Cianni

    Background/Objectives: The prevalence of gestational diabetes mellitus (GDM) has in-creased worldwide over recent years. This rise has been attributed to changes in diagnostic criteria and to evolving demographic and metabolic risk profiles. The present study aimed to evaluate temporal trends in GDM prevalence in Tuscany, Italy, from 2010 to 2021, and to assess whether these trends were associated with changes in major risk factors and GDM-associated maternal–neonatal outcomes. Methods: This population-based retrospective study included all singleton pregnancies recorded in regional Delivery Assistance Certificates (CeDAP) registry between 2010 and 2021 filled by midwives at almost every delivery in Tuscany. GDM was identified using vali-dated clinical algorithms, in accordance with IADPSG criteria implemented from 2013. Temporal trends in GDM prevalence, major risk factors (pregestational obesity, maternal age, origin from High Pressure Migration Countries—HPMC, and adverse maternal and neonatal outcomes were analyzed. Multivariate log linear Poisson regression models were used to assess independent asso-ciations and yearly trends after adjustment for confounders. Results: Among 266,394 pregnancies, mean GDM prevalence was 11.37% and increased progressively over time, despite a concomitant decline in birth rates. Parallel increases were observed in pregestational obesity and in pregnancies among women from HPMC. Multivariate analysis found pregestational obesity, older maternal age, and HPMC ethnicity as the main factors driving the rise in GDM prevalence over time. Ce-sarean deliveries and fetal macrosomia decreased over time, whereas preterm birth increased among GDM pregnancies. Adverse maternal and neonatal outcomes were more strongly associat-ed with pregestational obesity and maternal age than with GDM itself. Conclusions: A true in-crease in GDM prevalence occurred in Tuscany between 2010 and 2021, primarily driven by rising pregestational obesity, advanced maternal age, and HPMC migration. Fetal macrosomia, cesarean delivery, and neonatal distress, were primarily associated with pregestational obesity and mater-nal age, rather than GDM itself. These findings highlight the importance of preventive strategies targeting metabolic health before pregnancy and support the effectiveness of organized GDM screening and management in reducing adverse outcomes.

  • Open Access

    A transparent machine learning algorithm uncovers HbA1c patterns associated with therapeutic inertia in patients with type 2 diabetes and failure of metformin monotherapy

    by Nicoletta Musacchio, Rita Zilich, Davide Masi, Fabio Baccetti, Besmir Nreu, Carlo Bruno Giorda, Giacomo Guaita, Lelio Morviducci, Marco Muselli, Alessandro Ozzello, et al.


  • Open Access

    Overcoming Therapeutic Inertia in Type 2 Diabetes: Exploring Machine Learning-Based Scenario Simulation for Improving Short-Term Glycemic Control

    by Musacchio Nicoletta, Rita Zilich, Davide Masi, Fabio Baccetti, Besmir Nreu, Carlo Bruno Giorda, Giacomo Guaita, Lelio Morviducci, Marco Muselli, Alessandro Ozzello, et al.

    Background: International guidelines for diabetes care emphasize the urgency of promptly achieving and sustaining adequate glycemic control to reduce the occurrence of micro/macrovascular complications in patients with type 2 diabetes mellitus (T2DM). However, data from the Italian Association of Medical Diabetologists (AMD) Annals reveal that only 47% of T2DM patients reach appropriate glycemic targets, with approximately 30% relying on insulin therapy, either solely or in combination. This artificial intelligence analysis seeks to assess the potential impact of timely insulin initiation in all eligible patients via a “what-if” scenario simulation, leveraging real-world data. Methods: This retrospective cohort study utilized the AMD Annals database, comprising 1,186,247 T2DM patients from 2005 to 2019. Employing the Logic Learning Machine (LLM), we simulated timely insulin use for all eligible patients, estimating its effect on glycemic control after 12 months within a cohort of 85,239 patients. Of these, 20,015 were employed for the machine learning phase and 65,224 for simulation. Results: Within the simulated scenario, the introduction of appropriate insulin therapy led to a noteworthy projected 17% increase in patients meeting the metabolic target after 12 months from therapy initiation within the cohort of 65,224 individuals. The LLM’s projection envisages 32,851 potential patients achieving the target (hemoglobin glycated < 7.5%) after 12 months, compared to 21,453 patients observed in real-world cases. The receiver operating characteristic (ROC) curve analysis for this model demonstrated modest performance, with an area under the curve (AUC) value of 70.4%. Conclusions: This study reaffirms the significance of combatting therapeutic inertia in managing T2DM patients. Early insulinization, when clinically appropriate, markedly enhances patients’ metabolic goals at the 12-month follow-up.


  • Open Access

    Polybrominated Diphenyl Ethers (PBDEs) and Human Health: Effects on Metabolism, Diabetes and Cancer

    by Valerio Renzelli, Marco Gallo, Lelio Morviducci, Giampiero Marino, Alberto Ragni, Enzo Tuveri, Antongiulio Faggiano, Rossella Mazzilli, Annalisa Natalicchio, Maria Chiara Zatelli, et al.

    There is increasing evidence of the role of endocrine disruptors (EDs) derived from commonly employed compounds for manufacturing and processing in altering hormonal signaling and function. Due to their prolonged half-life and persistence, EDs can usually be found not only in industrial products but also in households and in the environment, creating the premises for long-lasting exposure. Polybrominated diphenyl ethers (PBDEs) are common EDs used in industrial products such as flame retardants, and recent studies are increasingly showing that they may interfere with both metabolic and oncogenic pathways. In this article, a multidisciplinary panel of experts of the Italian Association of Medical Diabetologists (AMD), the Italian Society of Diabetology (SID), the Italian Association of Medical Oncology (AIOM), the Italian Society of Endocrinology (SIE) and the Italian Society of Pharmacology (SIF) provides a review on the potential role of PBDEs in human health and disease, exploring both molecular and clinical aspects and focusing on metabolic and oncogenic pathways.


  • Open Access

    Metrics of Gender Differences in Mortality Risk after Diabetic Foot Disease

    by Giuseppe Seghieri, Elisa Gualdani, Piergiorgio Francia, Ilaria Campesi, Flavia Franconi, Graziano Di Cianni, Paolo Francesconi

    Background: The aim of this study was to clarify any gender differences in the mortality risk of people with DFD since patients with diabetic foot disease (DFD) are at a high risk of mortality and, at the same time, are more likely to be men. Methods: From regional administrative sources, the survival probability was retrospectively evaluated by the Kaplan-Meier method and using the Cox proportional-hazards model comparing people with DFD to those without DFD across the years 2011–2018 in Tuscany, Italy. Gender difference in mortality was evaluated by the ratio of hazard ratios (RHR) of men to women after initial DFD hospitalizations (n = 11,529) or in a cohort with prior history of DFD hospitalizations (n = 11,246). Results: In both cohorts, the survival probability after DFD was lower among women. Compared to those without DFD, after initial DFD hospitalizations, the mortality risk was significantly (18%) higher for men compared to women. This excess risk was particularly high after major amputations but also after ulcers, infections, gangrene, or Charcot, with a lower reduction after revascularization procedures among men. In the cohort that included people with a history of prior DFD hospitalizations, except for the risk of minor amputations being higher for men, there was no gender difference in mortality risk. Conclusions: In people with DFD, the overall survival probability was lower among women. Compared to those without DFD after a first DFD hospitalization, men were at higher risk of mortality. This excess risk disappeared in groups with a history of previous DFD hospitalizations containing a greater percentage of women who were older and probably had a longer duration of diabetes and thus becoming, over time, progressively frailer than men.